Misu, Tatsuro

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., et al. (2014) · Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 850

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

Kitley, J., Leite, M. I., Nakashima, I., Waters, P., McNeillis, B., Brown, R., Takai, Y., Takahashi, T., Misu, T., Elsone, L., et al. (2012) · Brain

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 438

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

Kaneko, K., Sato, D. K., Nakashima, I., Nishiyama, S., Tanaka, S., Marignier, R., Hyun, J.-W., Oliveira, L. M. D., Reindl, M., Seifert-Held, T., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments

Cited by 106

Pathogenic T cell responses against aquaporin 4

Pohl, M., Fischer, M.-T., Mader, S., Schanda, K., Kitic, M., Sharma, R., Wimmer, I., Misu, T., Fujihara, K., Reindl, M., et al. (2011) · Acta Neuropathologica

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 98

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD

Zeka, B., Hastermann, M., Kaufmann, N., Schanda, K., Pende, M., Misu, T., Rommer, P., Fujihara, K., Nakashima, I., Dahle, C., et al. (2016) · Acta Neuropathologica Communications

Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome

Cited by 65

Multiple sclerosis in Japan appears to be a milder disease compared to the UK

Piccolo, L., Kumar, G., Nakashima, I., Misu, T., Kong, Y., Wakerley, B., Ryan, S., Cavey, A., Fujihara, K., & Palace, J. (2015) · Journal of Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 57

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

Sato, T., Nagai, M., Watanabe, O., Misu, T., Takenouchi, N., Ohkubo, R., Ishihara, S., Tsuboi, Y., Katsuno, M., Nakagawa, M., et al. (2024) · Journal of Neurology

T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis

Cited by 21